| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0024 | 1 |